- Home
- FMN vs ACHV Comparison
FMN vs ACHV Comparison
Compare FMN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMN
- ACHV
- Stock Information
- Founded
- FMN 2002
- ACHV N/A
- Country
- FMN United States
- ACHV Canada
- Employees
- FMN N/A
- ACHV N/A
- Industry
- FMN Investment Managers
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FMN Finance
- ACHV Health Care
- Exchange
- FMN Nasdaq
- ACHV Nasdaq
- Market Cap
- FMN 86.2M
- ACHV 72.5M
- IPO Year
- FMN N/A
- ACHV N/A
- Fundamental
- Price
- FMN $10.54
- ACHV $3.83
- Analyst Decision
- FMN
- ACHV Strong Buy
- Analyst Count
- FMN 0
- ACHV 3
- Target Price
- FMN N/A
- ACHV $14.33
- AVG Volume (30 Days)
- FMN 22.8K
- ACHV 300.0K
- Earning Date
- FMN 01-01-0001
- ACHV 05-13-2025
- Dividend Yield
- FMN 3.86%
- ACHV N/A
- EPS Growth
- FMN N/A
- ACHV N/A
- EPS
- FMN N/A
- ACHV N/A
- Revenue
- FMN N/A
- ACHV N/A
- Revenue This Year
- FMN N/A
- ACHV N/A
- Revenue Next Year
- FMN N/A
- ACHV N/A
- P/E Ratio
- FMN N/A
- ACHV N/A
- Revenue Growth
- FMN N/A
- ACHV N/A
- 52 Week Low
- FMN $9.09
- ACHV $1.84
- 52 Week High
- FMN $11.31
- ACHV $5.58
- Technical
- Relative Strength Index (RSI)
- FMN 43.47
- ACHV 66.06
- Support Level
- FMN $10.51
- ACHV $2.89
- Resistance Level
- FMN $10.64
- ACHV $4.30
- Average True Range (ATR)
- FMN 0.06
- ACHV 0.30
- MACD
- FMN -0.01
- ACHV 0.10
- Stochastic Oscillator
- FMN 10.34
- ACHV 74.18
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.